Smart and Fit for Kidney Transplantation
Launched by UNIVERSITY OF ERLANGEN-NÜRNBERG MEDICAL SCHOOL · Sep 8, 2023
Trial Information
Current as of June 27, 2025
Recruiting
Keywords
ClinConnect Summary
The "Smart and Fit for Kidney Transplantation" trial is designed to help patients with chronic kidney disease who are waiting for a kidney transplant. The study will include 200 participants who are currently on dialysis. Researchers want to see if providing personalized nutritional advice and exercise support, along with a complete rehabilitation program, will improve health outcomes compared to a group that does not receive this support.
To participate, patients must be at least 18 years old, own a smartphone, and be willing to take part in rehabilitation during the study. They should also be physically and mentally able to engage in exercise and nutritional counseling. If you join the study, you can expect personalized guidance to help prepare for your transplant. This trial is actively recruiting participants, so if you think it could be a good fit for you or a loved one, consider reaching out for more information!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients must be on dialysis
- • Patients ≥ 18 years of age
- • Patients who own a smartphone
- • Patients must be willing to undergo inpatient rehabilitation within the project period
- • signed informed consent and data protection regulation
- Exclusion Criteria:
- • Patients who are not psychologically or physically able to take part in exercise promotion measures and/or nutritional counselling as well as psychological offers
- • Patients who have already participated in a similar project
About University Of Erlangen Nürnberg Medical School
The University of Erlangen-Nürnberg Medical School is a prestigious institution dedicated to advancing medical research and improving healthcare outcomes through innovative clinical trials. Renowned for its interdisciplinary approach, the medical school fosters collaboration among experts in various fields, enabling the development of cutting-edge therapies and treatment protocols. With a commitment to ethical standards and patient safety, the institution actively contributes to the global medical community by conducting rigorous clinical studies aimed at enhancing the understanding and management of diverse health conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Erlangen, Bavaria, Germany
Patients applied
Trial Officials
Mario Schiffer, Prof.
Study Director
Universitätsklinikum Erlangen
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported